Search - tctmd.com

Displaying 41 - 60 of 123

Sort: Relevancy | Date

Presentation TVT 2022

POINT: U.S. Reflections… Class 1 = ≥ 65 yo

Presenter: Philippe Genereux

June 08, 2022

Presentation TVT 2022

Transcatheter versus surgical aortic valve replacement for severe aortic stenosis: a meta-analysis of randomized clinical trials

Presenter: Yousif Ahmad

June 08, 2022

Presentation TVT 2022

Beyond Aortic Stenosis: TAVR Outside the Box

Presenter: Marissa Munsayac

June 08, 2022

News Conference News TVT 2021

Post-TAVI Pacemaker Rates Down in the US, but ‘Still Quite High’

Todd Neale

July 23, 2021

Presentation TVT 2021

4th Aortic Bioprosthesis (V-i-V-i-V-i-V): Lifetime Management is the Key for Aortic Stenosis

Presenter: Pradeep Yadav

July 21, 2021

Presentation TVT 2021

AI-Based Network Tomography for Understanding Phenotypic Presentations in Aortic Stenosis

Presenter: Partho Sengupta

July 21, 2021

Presentation TVT 2021

Detection of Aortic Stenosis, Aortic Regurgitation, and Mitral Regurgitation Using Deep Learning Analysis of the ECG

Presenter: Pierre Elias

July 21, 2021

Presentation TVT 2021

Hemodynamic Consideration of SAVR &ViV-TAVR

Presenter: Tsuyoshi Kaneko

July 21, 2021

Presentation TVT 2021

Prosthesis Patient Mismatch in TAVR vs SAVR: Much Ado About Nothing?

Presenter: Houman Khalili

July 21, 2021

Presentation TVT 2021

Post-procedural Hemodynamics: What to Make of Invasive & Echocardiographic Transvalvular Gradients?

Presenter: Amr Abbas

July 21, 2021

Presentation TVT 2021

Echocardiography & Aortic Stenosis Pre-TAVR: Pitfalls & Pearls

Presenter: Dee Dee Wang

July 21, 2021

News Conference News TVT 2021

TAVI Outcomes Similar in Low-Risk Bicuspid, Tricuspid Aortic Stenosis at 1 Year

Todd Neale

July 20, 2021

Presentation TVT 2021

Comparison of 1-Year Outcomes After Transcatheter Aortic Valve Replacement in Low-Risk Patients With Severe Bicuspid and Tricuspid Aortic Valve Stenosis

Presenter: John Forrest

July 20, 2021

News Conference News TVT 2020

Stroke in TAVR: Full Impact of Embolic Devices, Anticoagulants, Technique Remain Unclear

Todd Neale

June 25, 2020

News Conference News TVT 2020

Device Explants After TAVR Rare but Risky

Michael O'Riordan

June 24, 2020

News Conference News TVT 2020

Reduced Leaflet Motion After TAVR: No Link to Impaired Hemodynamics, Events

Michael O'Riordan

June 23, 2020

News Conference News TVT 2020

Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years

Michael O'Riordan

June 22, 2020

Presentation TVT 2020

Transcatheter Aortic Valve Replacement using an Evolut PRO Bioprosthesis in Low Risk Patients with Aortic Stenosis

Presenter: Bruce Rutkin

June 20, 2020

News Conference News TVT 2020

Skipping Predilatation in Low-risk TAVR Patients Does Not Mar Outcomes

L.A. McKeown

June 19, 2020

News Conference News TVT 2019

Better Hemodynamics, Less Mismatch With Self-Expanding TAVR vs Surgery

Michael O'Riordan

June 20, 2019

Advertisement

POINT: U.S. Reflections… Class 1 = ≥ 65 yo

Transcatheter versus surgical aortic valve replacement for severe aortic stenosis: a meta-analysis of randomized clinical trials

Beyond Aortic Stenosis: TAVR Outside the Box

Post-TAVI Pacemaker Rates Down in the US, but ‘Still Quite High’

4th Aortic Bioprosthesis (V-i-V-i-V-i-V): Lifetime Management is the Key for Aortic Stenosis

AI-Based Network Tomography for Understanding Phenotypic Presentations in Aortic Stenosis

Detection of Aortic Stenosis, Aortic Regurgitation, and Mitral Regurgitation Using Deep Learning Analysis of the ECG

Hemodynamic Consideration of SAVR &ViV-TAVR

Prosthesis Patient Mismatch in TAVR vs SAVR: Much Ado About Nothing?

Post-procedural Hemodynamics: What to Make of Invasive & Echocardiographic Transvalvular Gradients?

Echocardiography & Aortic Stenosis Pre-TAVR: Pitfalls & Pearls

TAVI Outcomes Similar in Low-Risk Bicuspid, Tricuspid Aortic Stenosis at 1 Year

Comparison of 1-Year Outcomes After Transcatheter Aortic Valve Replacement in Low-Risk Patients With Severe Bicuspid and Tricuspid Aortic Valve Stenosis

Stroke in TAVR: Full Impact of Embolic Devices, Anticoagulants, Technique Remain Unclear

Device Explants After TAVR Rare but Risky

Reduced Leaflet Motion After TAVR: No Link to Impaired Hemodynamics, Events

Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years

Transcatheter Aortic Valve Replacement using an Evolut PRO Bioprosthesis in Low Risk Patients with Aortic Stenosis

Skipping Predilatation in Low-risk TAVR Patients Does Not Mar Outcomes

Better Hemodynamics, Less Mismatch With Self-Expanding TAVR vs Surgery

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content